These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 17461889)

  • 1. Levetiracetam: the profile of a novel anticonvulsant drug-part I: preclinical data.
    De Smedt T; Raedt R; Vonck K; Boon P
    CNS Drug Rev; 2007; 13(1):43-56. PubMed ID: 17461889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levetiracetam: part II, the clinical profile of a novel anticonvulsant drug.
    De Smedt T; Raedt R; Vonck K; Boon P
    CNS Drug Rev; 2007; 13(1):57-78. PubMed ID: 17461890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levetiracetam.
    Krishna K; Raut AL; Gohel KH; Dave P
    J Assoc Physicians India; 2011 Oct; 59():656-8. PubMed ID: 22479748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levetiracetam: the preclinical profile of a new class of antiepileptic drugs?
    Klitgaard H
    Epilepsia; 2001; 42 Suppl 4():13-8. PubMed ID: 11564119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levetiracetam as an antiepileptic, neuroprotective, and hyperalgesic drug.
    Cortes-Altamirano JL; Olmos-Hernández A; Bonilla-Jaime H; Bandala C; González-Maciel A; Alfaro-Rodríguez A
    Neurol India; 2016; 64(6):1266-1275. PubMed ID: 27841198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefit of combination therapy in epilepsy: a review of the preclinical evidence with levetiracetam.
    Kaminski RM; Matagne A; Patsalos PN; Klitgaard H
    Epilepsia; 2009 Mar; 50(3):387-97. PubMed ID: 18627416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levetiracetam: treatment in epilepsy.
    Ben-Menachem E
    Expert Opin Pharmacother; 2003 Nov; 4(11):2079-88. PubMed ID: 14596661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacodynamic and pharmacokinetic characterization of interactions between levetiracetam and numerous antiepileptic drugs in the mouse maximal electroshock seizure model: an isobolographic analysis.
    Luszczki JJ; Andres MM; Czuczwar P; Cioczek-Czuczwar A; Ratnaraj N; Patsalos PN; Czuczwar SJ
    Epilepsia; 2006 Jan; 47(1):10-20. PubMed ID: 16417526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An assessment of levetiracetam as an anti-epileptic drug.
    Jain KK
    Expert Opin Investig Drugs; 2000 Jul; 9(7):1611-24. PubMed ID: 11060765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brivaracetam: Rationale for discovery and preclinical profile of a selective SV2A ligand for epilepsy treatment.
    Klitgaard H; Matagne A; Nicolas JM; Gillard M; Lamberty Y; De Ryck M; Kaminski RM; Leclercq K; Niespodziany I; Wolff C; Wood M; Hannestad J; Kervyn S; Kenda B
    Epilepsia; 2016 Apr; 57(4):538-48. PubMed ID: 26920914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levetiracetam: a new therapeutic option for refractory epilepsy.
    Pinto A; Sander JW
    Int J Clin Pract; 2003 Sep; 57(7):616-21. PubMed ID: 14529064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levetiracetam: a different approach to the pharmacotherapy of epilepsy.
    Welty TE; Gidal BE; Ficker DM; Privitera MD
    Ann Pharmacother; 2002 Feb; 36(2):296-304. PubMed ID: 11847952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy.
    Klitgaard H; Matagne A; Gobert J; Wülfert E
    Eur J Pharmacol; 1998 Jul; 353(2-3):191-206. PubMed ID: 9726649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the novel antiepileptic drug levetiracetam on spontaneous recurrent seizures in the rat pilocarpine model of temporal lobe epilepsy.
    Glien M; Brandt C; Potschka H; Löscher W
    Epilepsia; 2002 Apr; 43(4):350-7. PubMed ID: 11952764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between levetiracetam and cardiovascular drugs against electroconvulsions in mice.
    Lukawski K; Raszewski G; Czuczwar SJ
    Pharmacol Rep; 2014 Dec; 66(6):1100-5. PubMed ID: 25443741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levetiracetam: antiepileptic properties and protective effects on mitochondrial dysfunction in experimental status epilepticus.
    Gibbs JE; Walker MC; Cock HR
    Epilepsia; 2006 Mar; 47(3):469-78. PubMed ID: 16529608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticonvulsant properties of the novel nootropic agent nefiracetam in seizure models of mice and rats.
    Kitano Y; Komiyama C; Makino M; Takasuna K; Takazawa A; Sakurada S
    Epilepsia; 2005 Jun; 46(6):811-8. PubMed ID: 15946322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacology and clinical results of levetiracetam (E Keppra(®) Tablets), a new antiepileptic drug].
    Ishii Y; Tanaka T
    Nihon Yakurigaku Zasshi; 2011 Feb; 137(2):95-102. PubMed ID: 21321459
    [No Abstract]   [Full Text] [Related]  

  • 19. Anticonvulsant effects of levetiracetam and levetiracetam-diazepam combinations in experimental status epilepticus.
    Mazarati AM; Baldwin R; Klitgaard H; Matagne A; Wasterlain CG
    Epilepsy Res; 2004 Feb; 58(2-3):167-74. PubMed ID: 15120747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unidirectional cross-tolerance from levetiracetam to carbamazepine in amygdala-kindled seizures.
    Zhang ZJ; Xing GQ; Russell S; Obeng K; Post RM
    Epilepsia; 2003 Dec; 44(12):1487-93. PubMed ID: 14636317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.